Safety and Efficacy of Duloxetine in Youth With MDD

<p>Is duloxetine a viable option for youth with MDD? In this episode, we discuss the need for additional medication options in youth with depression as well as an RCT of duloxetine to assess its efficacy and a label extension trial to evaluate its long-term safety.</p> <p>Faculty: David Rosenberg, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC218" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-04-2743?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC218" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: CAP Smart Takes Vol. 04</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/efficacy-and-safety-of-duloxetine-in-children-and-adolescents-with-mdd-in-japan-2743-5298?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC218" target="_blank" rel="noopener"><strong>Efficacy and Safety of Duloxetine in Children and Adolescents With MDD in Japan</strong></a></li> </ul>